Goldman Sachs Maintains Baxter International Inc(BAX.US) With Hold Rating, Maintains Target Price $36
Goldman Sachs analyst David Roman maintains $Baxter International Inc(BAX.US)$ with a hold rating, and maintains the target price at $36.According to TipRanks data, the analyst has a success rate of 7
How Is The Market Feeling About Baxter Intl?
Baxter Intl's (NYSE:BAX) short percent of float has fallen 20.54% since its last report. The company recently reported that it has 7.97 million shares sold short, which is 2.05% of all regular shares
Baxter to Present at Goldman Sachs 45th Annual Global Healthcare Conference
Express News | NYSE Order Imbalance 192435.0 Shares on Buy Side
Express News | NYSE Order Imbalance 52186.0 Shares on Sell Side
The Most Crowded Longs and Shorts in U.S. Med-Tech for May - UBS
Express News | NYSE Order Imbalance 144512.0 Shares on Buy Side
Unusual Options Activity: UAL, BLK and Others Attract Market Bets, UAL V/OI Ratio Reaches 155.2
EST Jun 4th Morning Delivery - In the last two hours of trading, 8 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.Of
Express News | NYSE Order Imbalance 102204.0 Shares on Sell Side
Is Baxter International Inc. (NYSE:BAX) Trading At A 42% Discount?
Key Insights Using the 2 Stage Free Cash Flow to Equity, Baxter International fair value estimate is US$58.77 Current share price of US$34.09 suggests Baxter International is potentially 42% underva
Unusual Options Activity: SLB, U and Others Attract Market Bets, SLB V/OI Ratio Reaches 158.6
EST May 31st Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.O
Express News | Baxter International Inc : Goldman Sachs Initiates Coverage With Neutral Rating; Price Target $36
Express News | NYSE Order Imbalance 181730.0 Shares on Sell Side
Baxter International (NYSE:BAX) Has Announced A Dividend Of $0.29
Unveiling 5 Analyst Insights On Baxter Intl
In the latest quarter, 5 analysts provided ratings for Baxter Intl (NYSE:BAX), showcasing a mix of bullish and bearish perspectives.The following table encapsulates their recent ratings, offering a gl
Baxter International Initiated at Neutral by Goldman Sachs
Baxter International Initiated at Neutral by Goldman Sachs
Express News | Goldman Sachs Initiates Coverage On Baxter Intl With Neutral Rating, Announces Price Target of $36
Express News | NYSE Order Imbalance 122037.0 Shares on Sell Side
Express News | New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as Hdx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Express News | Baxter International Announces New Data Showing HDx Therapy With Theranova Dialyzer Reduces All-Cause Mortality Risk By 25% In Four-Year Study Involving 1,000 Dialysis Patients
No Data